Where is TIAP's headquarters located?

TIAP's headquarters is located in Toronto (Canada).

How big is TIAP's investment team?

TIAP has a team of 23, including 12 partners.

How many companies has TIAP invested in?

TIAP has invested in 63 companies, including Flybits & Deep Genomics.

Which companies has TIAP invested in lately?

Grey Matter Neurosciences & Radiant Biotherapeutics are the latest investments by TIAP.

How many exits has TIAP been involved in?

TIAP's portfolio has seen 9 acquisitions.

TIAP - 2026 Investor Profile, Portfolio, Team & Investment Trends

TIAP, an accelerator and incubator program founded in 2008, is based in Toronto, Canada. With a presence in 2 countries, it has supported around 63 startups in sectors like Life Sciences, Enterprise Applications. As of Jun 2026, TIAP has witnessed 9 portfolio exits. Most notable companies in its portfolio include Flybits, Deep Genomics and ODAIA. The program is backed by a team of 23 people who primarily support Seed startups based in Canada. Its latest investment was a $14M Seed round in Grey Matter Neurosciences on Jan 23, 2025, which also saw participation from Wittington Ventures and Ontario Brain Institute.

Key Metrics

Founded Year

2008

Location

Toronto, Canada

Portfolio Companies

Flybits, Deep Genomics & 61 more

Sectors of Investment

Life Sciences, Enterprise Applications & 15 more

Stages of Investment

Seed & Series A

Locations of Investment

Canada & United States

View TIAP's full profile

TIAP has a portfolio of 63 companies. Their most notable investments are in HDAX and Whirlscape.Their portfolio spans across Canada and United States. They have invested in Life Sciences, Enterprise Applications, High Tech and 14 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by TIAP:

1. Flybits

Flybits is a banking channel for enterprises. It features Context-as-a-Service platform that enables banks and other enterprises to create and deliver context-aware mobile applications. It features tools for creating personalized mobile experiences on top of traditional app development and simple location-based services. It supports the iOS and Android devices and helps in scaling to handle the data sources of the emerging internet-of-things.

Key facts about Flybits

Founded Year: 2013
Location: Toronto (Canada)
Stage: Series C
Total Funding till date: $50M
Employee Count: 62 as on Apr 30, 2026
Investors: TD Bank, Mastercard and 17 Others
Latest Funding Round: Series C, Jul 16, 2019, $*****
Highlight: Editors' Pick

2. Deep Genomics

AI-powered platform for RNA biology to accelerate genetic therapy discovery. It focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic conditions. Its offers proprietary AI platform including the flagship model BigRNA that uses machine learning to analyze vast RNA biology data, identify therapeutic targets, and evaluate potential therapeutic candidates efficiently than traditional approaches. The technology helps accelerate early stages of drug discovery and design of RNA-based therapies.

Key facts about Deep Genomics

Founded Year: 2014
Location: Toronto (Canada)
Stage: Series C
Total Funding till date: $238M
Employee Count: 108 as on Apr 30, 2026
Investors: Fidelity Investments, True Ventures and 16 Others
Latest Funding Round: Series C, Jul 28, 2021, $*****
Highlight: Editors' Pick

3. ODAIA

Provider of AI-powered intelligence platform for pharmaceutical commercial and sales teams. The platform delivers relevant targets, prioritized call lists, and personalized insights. It helps sales representatives engage with healthcare professionals. The platform identifies trends and patterns in engagements, empowering managers with actionable insights. It offers dynamic segmentation and targeting to optimize commercial resources.

Key facts about ODAIA

Founded Year: 2018
Location: Toronto (Canada)
Stage: Series B
Total Funding till date: $44.5M
Employee Count: 112 as on Apr 30, 2026
Investors: Inovia Capital, Alumni Ventures and 18 Others
Latest Funding Round: Series B, May 01, 2023, $*****
Highlight: Editors' Pick

4. BlueDot

Provider of infectious disease intelligence platform. It models how infectious diseases can spread and impact populations globally by analyzing big data such as the annual movements, human, animal, and insect population data, climate data from satellites, and news reports of disease outbreaks.

Key facts about BlueDot

Founded Year: 2013
Location: Toronto (Canada)
Valuation: $*****
Stage: Series A
Total Funding till date: $9.95M
Employee Count: 92 as on Apr 30, 2026
Investors: Golden Ventures, MaRS Discovery District and 6 Others
Latest Funding Round: Grant (prize money), Jan 17, 2023, $*****
Highlight: Editors' Pick

5. EBT Medical

EBT Medical is developing non-invasive neurostimulation therapies and disease state support systems for pelvic floor disorders, starting with overactive bladder. It delivers long-lasting pharmaceutical or invasive therapy-equivalent efficacy without the side-effects, invasiveness, or costs that are typically associated with those therapies.

Key facts about EBT Medical

Founded Year: 2014
Location: Toronto (Canada)
Stage: Series A
Total Funding till date: $10M
Employee Count: 11 as on Apr 30, 2026
Investors: University of Toronto, Bizistech and 8 Others
Latest Funding Round: Series A, Nov 19, 2019, $*****

View the full list of portfolio companies

TIAP has invested in 63 companies over the last 16 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Grey Matter Neurosciences and most recent follow-on round was in Radiant Biotherapeutics.

Here are TIAP's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	0	0	0
2025	1	0	1
2024	1	1	2
2023	1	0	1
2022	1	0	1
2021	1	0	1
2020	0	0	0
2019	2	0	2
2018	0	1	1
2017	1	0	1

View all investments by TIAP

TIAP has made 23 investments in Seed stage with an average round size of $2.69M and 3 investments in Series A stage with an average round size of $3.94M.

Here are TIAP's investments by stage:

Stage of entry	No. of Investments
Seed	23
Series A	3

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Sustainability Tech. Notably, it has invested in 54 Tech companies, 47 Enterprise (B2B) companies, 32 Software companies and at least 12 companies focusing on Consumer (B2C).

Here are TIAP's investments by sector:

Sector	No. of Investments
Life Sciences	13
Enterprise Applications	9
HealthTech	6
High Tech	5
Sustainability Tech	4
Others	14

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has made most investments in Canada (23), followed by United States where it has made 3 investments.

Here are TIAP's investments by geography:

Country	No. of Investments
Canada	23
United States	3

Note: We have considered here, only first round of investments

View all investments by TIAP

TIAP has not made any investment in 2026 so far.

Here are the most recent investments by TIAP:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
Jan 23, 2025	Grey Matter Neurosciences	Canada	Seed	1473	Wittington Ventures [+2]
Sep 11, 2024	Radiant Biotherapeutics	Canada	Series A	5935	Gates [+5]
Sep 05, 2024	HDAX	Canada	Seed	6839	SeedFolio [+3]
Apr 25, 2023	Radiant Biotherapeutics	Canada	Seed	6277	Amplitude [+4]
Sep 26, 2022	DAMONA Pharmaceuticals	Canada	Seed	5433	Noetic Psychedelic Fund [+1]

See more recent investments made by TIAP

9 companies from TIAP's portfolio have been acquired. The most recent acquisition was Bitnobi in Jan 2025 by Myant for $*****.

Here are TIAP's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Bitnobi	Jan 16, 2025	-	-	5445
QD Solar	Jun 18, 2024	Feb 13, 2017	Series A	6013
Slyce	Sep 22, 2021	-	-	5031
CoHealth	Oct 28, 2020	-	-	3458
LegUp Computing	Oct 21, 2020	-	-	5573

View all acquired companies in TIAP's portfolio

TIAP has a team of 23 members including 12 Partners, 1 Venture Partner and 3 Principals located in Canada and United States. TIAP's team does not sit on the board of any company as of now.

Here is a list of top team members in TIAP:

Name	Designation	Location	Board Memberships	Contact Details
Hassan Jaferi	Partner	Toronto	-	1 Email
Angus Grant	Partner	Boston	-	1 Email
Leah Cowen	Partner	Toronto	-	1 Email
Chris Adams	Partner	Toronto	-	1 Email
Ido Kaminsky	Partner	Vaughan	-	1 Email
Michelle Kirkwood	Partner	Ajax	-	1 Email
Philip Goldbach	Partner	Toronto	-	1 Email
Bradly Wouters	Partner	Toronto	-	1 Email
Tanya Borsuk	Partner	Highland Park	-	1 Email
Jessica Chutter	Partner	-	-	1 Email
Joyce Lin	Partner	Toronto	-	1 Email

View team details of TIAP

Over the past 16 years, 77 investors have co-invested in TIAP's portfolio companies. This includes funds and angels.

Invested before TIAP: Mitacs, Canadian Glycomics Network and 6 others have invested in rounds before TIAP. There is 1 company where Mitacs has invested before TIAP and 1 company where Canadian Glycomics Network has invested before TIAP.
Top Co-investors of TIAP: 32 investors entered a company along with TIAP. These include investors like UTEST (5 companies).
Invested after TIAP: A total of 37 investors have invested in TIAP's portfolio after their investments. Top Investors include Canadian Space Agency (2 companies) and Y Combinator (2 companies).